Beijing SL Pharmaceutical Co., Ltd. is principally engaged in the development, production and sale of gene engineering drugs. The Company provides four categories of products: biological products, including rhG-CSF injections, interleukin-2 injections, rhIL-11 injections and rh-bFGF; biochemicals, such as cytidine disodium triphosphate for injection, calcium folinate for injection, salmon calcitonin injection, coenzyme complex for injection, netilmicin sulfate injection, matrine injection and ciclosporin injection; tablets and capsules, including desloratadine orally-disintegrating tablets, zaleplon capsules, naftopidil tablets, tropisetron hydrochloride capsules, telmisartan tablets, metformin hydrochloride and glyburide tablets and stavudine capsules, and health-care food, including Hongxin Capsule. It distributes its products in domestic and overseas markets.